Lab Notes: Code Bio makes potential $2B deal; Marinus suffers Covid-related setback
February 25, 2022 at 13:35 PM EST
The Center for Breakthrough Medicines has formed a cell and gene therapy partnership with a Philadelphia CRO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|